Details
Role
Honorary Fellow
Top Publications
-
Meyran, D, Zhu, J, Buttler, J, Tantalo, D, Neeson, M, Ekert, P, Kershaw, M, Trapani, J, Darcy, P, Neeson, P.
DEVELOPMENT OF NEXT GENERATION CAR'S TARGETING THE LEWIS Y ANTIGEN FOR THE TREATMENT OF CANCER.
Cytotherapy
21(5)
:
e15
2019
view publication
-
Tsoli, M, Lau, L, Barahona, P, Mayoh, C, Failes, T, Wong, M, Sherstyuk, A, Gifford, AJ, Kumar, A, Mould, E, et al.
THER-23. RESULTS OF THE ZERO CHILDHOOD CANCER INTEGRATED PRECISION MEDICINE PLATFORM FOR PAEDIATRIC HIGH-RISK BRAIN TUMOURS.
Neuro-Oncology
21(Supplement_2)
:
ii118 -ii118
2019
view publication
-
Gayden, T, Sepulveda, FE, Khuong-Quang, D-A, Pratt, J, Valera, ET, Garrigue, A, Kelso, S, Sicheri, F, Mikael, LG, Hamel, N, et al.
Author Correction: Germline HAVCR2 mutations altering TIM-3 characterize subcutaneous panniculitis-like T cell lymphomas with hemophagocytic lymphohistiocytic syndrome.
Nature Genetics
51(1)
:
196 -196
2019
view publication
-
Tsoli, M, Wadham, C, Pinese, M, Failes, T, Joshi, S, Mould, E, Yin, JX, Gayevskiy, V, Kumar, A, Kaplan, W, et al.
Integration of genomics, high throughput drug screening, and personalized xenograft models as a novel precision medicine paradigm for high risk pediatric cancer.
Cancer Biology & Therapy
19(12)
:
1078 -1087
2018
view publication
-
Gayden, T, Sepulveda, FE, Khuong-Quang, D-A, Pratt, J, Valera, ET, Garrigue, A, Kelso, S, Sicheri, F, Mikael, LG, Hamel, N, et al.
Germline HAVCR2 mutations altering TIM-3 characterize subcutaneous panniculitis-like T cell lymphomas with hemophagocytic lymphohistiocytic syndrome.
Nature Genetics
50(12)
:
1650 -1657
2018
view publication
